Moritz Mirna

paracelsus private medical university

H指数:16

被引数:1,123

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reply to: Recurrent Takotsubo: Interpreting the 5.9-Fold 30-Day Cardiovascular Mortality Signal

回复：复发性Tako-tsubo：解读30天心血管死亡率的5.9倍信号

MEDICAL PRINCIPLES AND PRACTICE

IF2.2

2025-11-010

Takotsubo Syndrome Recurrence: A Trigger for Increased 30-Day Cardiovascular Mortality

takotsubo综合征复发：30天心血管死亡增加的诱因

MEDICAL PRINCIPLES AND PRACTICE

IF2.2

2025-04-010

Novel Biomarkers as Potential Predictors of Decompensated Advanced Chronic Heart Failure-Single Center Study

新型生物标志物作为晚期慢性心力衰竭失代偿的潜在预测因子-单中心研究

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-11-140

OAAI

Visual grading of valvular regurgitation is inferior to measurement - results from the VIAVA-study (VIsual Assessment of VAlvular Regurgitation)

ECHO RESEARCH AND PRACTICE

IF2.4

2024-11-110

OAAI

Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-07-161

OAAI

Reply to: The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2024-03-010

PRE

Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction - a meta-analysis

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2023-10-012

OAAI

MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction

CELLS

IF5.2

2023-09-273

OAAI

Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-08-311

OAAI

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion

阵发性或持续性房颤患者体外直流电复律后房颤复发的生物标志物

BIOMEDICINES

IF3.9

2023-05-164

OAAI

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest

CELLS

IF5.2

2022-10-251

OAAI

A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome - The SAlzburg MYocarditis (SAMY) Score

FRONTIERS IN MEDICINE

IF3

2022-06-092

OAAI

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals

LIFE-BASEL

IF3.4

2022-05-261

OAAI

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome-A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-05-253

OAAI

Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI-Same Same but Different?

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-05-251

OAAI

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients

JOURNAL OF PERSONALIZED MEDICINE

IF3

2022-05-234

OAAI

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

LIFE-BASEL

IF3.4

2022-03-084

OAAI

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome

用Betablockers进行预处理，这是Takotsubo综合征不良心血管事件的潜在预测因素

BIOMEDICINES

IF3.9

2022-02-162

OAAI

How spaceflight challenges human cardiovascular health

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2022-02-1129

PRE

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis

FRONTIERS IN MEDICINE

IF3

2022-02-029

OAAI

Moritz Mirna

个人简介

教育背景

工作经历

荣誉奖项

研究方向